PT-141+ is not intended to diagnose, treat, cure, or prevent any disease
The MHRA's stated read is that there is little credible scientific evidence behind the claims, the products are unlicensed, and the marketing has run a long way ahead of the data
Primarily through amyloid-preventing substitutions at residues 20-29, addition of the C18 fatty diacid lipid group, and optimization of the linker
Where Semax and Dihexa are primarily about optimization and growth, Cerebrolysin is fundamentally about protection and repair
Diese Bedingungen unterliegen sterreichischem Recht
The cardio-ankle vascular index (CAVI), a prognostic marker for cardiovascular events, declined by approximately 0.2 points bilaterally, reflecting improved arterial elasticity